Cargando…

Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis

BACKGROUND: There are different and inconsistent conclusions regarding the genetic relationship between the human tumor suppressor p53 (TP53) rs1042522 polymorphism and the risk of oral squamous cell carcinoma (OSCC) and oral leukoplakia (OL). Therefore, the aim of the study was to comprehensively r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zhen, Gao, Wei, Cui, Jiang-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102817/ https://www.ncbi.nlm.nih.gov/pubmed/30126398 http://dx.doi.org/10.1186/s12903-018-0603-6

Ejemplares similares

MON-519 In Silico Analysis of rs1042522 and rs1042522 Polymorphic Variants of TP53 Gene
por: Bó, Izabela Dal, et al.
Publicado: (2020)

TP53 rs1042522 polymorphism and early-onset breast cancer
por: Icen-Taskin, Irmak, et al.
Publicado: (2020)

Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis
por: Fan, Song, et al.
Publicado: (2017)

The TP53 gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese children
por: He, Jing, et al.
Publicado: (2017)

Association of the TP53 rs1042522 C>G polymorphism and hepatoblastoma risk in Chinese children
por: Yang, Tianyou, et al.
Publicado: (2019)

Association of TP53 rs1042522 C>G Polymorphism with Glioma Risk in Chinese Children
por: Liao, Fan, et al.
Publicado: (2022)

The Functional TP53 rs1042522 and MDM4 rs4245739 Genetic Variants Contribute to Non-Hodgkin Lymphoma Risk
por: Fan, Chuanbo, et al.
Publicado: (2014)

Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis
por: Huang, Xin, et al.
Publicado: (2019)

The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis
por: Bulgakova, O., et al.
Publicado: (2020)

Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review
por: Yu, Meijia, et al.
Publicado: (2022)

Human TP53 polymorphism (rs1042522) modelled in mouse does not affect glucose metabolism and body composition
por: Reiling, Erwin, et al.
Publicado: (2014)

TP53 rs1042522 C>G polymorphism and Wilms tumor susceptibility in Chinese children: a four-center case–control study
por: Liu, Peng, et al.
Publicado: (2019)

The complementary effect of rs1042522 in TP53 and rs1805007 in MC1R is associated with an elevated risk of cutaneous melanoma in Latvian population
por: Ozola, Aija, et al.
Publicado: (2019)

Association of TP53 rs1042522 G > C, MDM2 rs2279744 T > G, and miR-34b/c rs4938723 T > C polymorphisms with aneuploidy pregnancy susceptibility
por: Chan, Ying, et al.
Publicado: (2023)

TP53 gene rs1042522 allele G decreases neuroblastoma risk: a two-centre case-control study
por: Zhang, Jiao, et al.
Publicado: (2019)

Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma
por: de-Assis, Eliene M., et al.
Publicado: (2012)

Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
por: Patil, Ashok, et al.
Publicado: (2015)

The Dilemma of TP53 Codon 72 Polymorphism (rs1042522) and Breast Cancer Risk: A Case-Control Study and Meta-Analysis in The Iranian Population
por: Afzaljavan, Fahimeh, et al.
Publicado: (2020)

TP53 Gene 72 Arg/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia
por: Ounalli, Asma, et al.
Publicado: (2023)

The Investigation of Associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
por: Bekampytė, Justina, et al.
Publicado: (2021)

TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study
por: Datkhile, Kailas D, et al.
Publicado: (2023)

Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study
por: Tripon, Florin, et al.
Publicado: (2020)

Oral Squamous Papilloma Mimicking Oral Verrucous Leukoplakia
por: Tebcherany, Houda, et al.
Publicado: (2022)

TP53Gene Pro72Arg(rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population
por: Asadi, Milad, et al.
Publicado: (2017)

Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
por: Popek-Marciniec, Sylwia, et al.
Publicado: (2023)

Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review
por: Hosmani, Jagadish, et al.
Publicado: (2021)

In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia
por: Makarev, Eugene, et al.
Publicado: (2017)

Stathmin! An Immunohistochemical Analysis of the Novel Marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia
por: Vadla, Purnima, et al.
Publicado: (2020)

Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma
por: Ding, Xu, et al.
Publicado: (2018)

TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population
por: Basabaeen, Ameen Abdulaziz Mohammed, et al.
Publicado: (2019)

Potency of Pfeiffer’s Crystallization to Analyze Oral Leukoplakia and Squamous Cell Carcinoma
por: Makkar, Vanshika, et al.
Publicado: (2020)

Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma
por: Lin, Lin, et al.
Publicado: (2016)

CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma
por: Ye, Xiaojing, et al.
Publicado: (2018)

Evaluation of genotoxicity by micronucleus assay in oral leukoplakia and oral squamous cell carcinoma with deleterious habits
por: Singam, Praveen Kumar, et al.
Publicado: (2019)

A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study
por: Srinivasan, Vaishnavi, et al.
Publicado: (2023)

Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer
por: Lin, Ying-Mei, et al.
Publicado: (2018)

P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy
por: Abd-Rabou, Ahmed A., et al.
Publicado: (2015)

Study of Association between Pre-Senile Cataracts and the Polymorphisms rs2228000 in XPC and rs1042522 in p53 in Spanish Population
por: López Valverde, Gloria, et al.
Publicado: (2016)

Proliferative verrucous leukoplakia misdiagnosed as oral leukoplakia
por: Gupta, Rajesh Kumar, et al.
Publicado: (2017)

Expression of Mucin 4 in leukoplakia and oral squamous cell carcinoma: An immunohistochemical study
por: Narashiman, Sangeetha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tsi6hrl4h1kg1par7gusb6va01